Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Biomarkers
Treatment
Clinical Care
Prevention
View all Topics
Conferences
AAIC 2023
BNA 2023
AD/PD 2023
ARUK 2023
CTAD 2022
AAIC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Frontotemporal Dementia
2:04
The promise of tau aggregation inhibitors in dementia
Sonya Miller
• 17 Jul 2023
1:37
Investigating TDP-43 pathology with cryptic exons
Matthew Keuss
• 17 Mar 2023
3:27
TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD
Matthew Keuss
• 17 Mar 2023
1:27
de novo proteins generated from cryptic exon translation in ALS & FTD
Matthew Keuss
• 17 Mar 2023
2:20
Targeting cellular senescence in tauopathies
Rakez Kayed
• 17 Aug 2022
1:26
Next steps in dementia biomarkers
Marc Suárez-Calvet
• 26 Jul 2022
1:57
Anti-HMGB1 agents for the treatment of Alzheimer’s disease
Rakez Kayed
• 17 Aug 2022
4:45
Tau fibrils versus tau oligomers in neurotoxicity and neurodegeneration
Rakez Kayed
• 17 Aug 2022
3:14
Tau oligomers trigger astrocyte senescence in tauopathy models
Rakez Kayed
• 17 Aug 2022
3:53
Biomarkers for frontotemporal dementia
Julio Rojas-Martinez
• 4 Apr 2022
1:21
Plasma NfL as a biomarker for frontotemporal dementia
Julio Rojas-Martinez
• 4 Apr 2022
1:14
Diagnostic tools for neurodegenerative disease
Davide Tampellini
• 18 Mar 2022
0:57
Dipeptide repeat proteins and the NLRP3 inflammasome in FTD
Sarah Ryan
• 1 Mar 2022
1:19
Next steps for research into the NLRP3 inflammasome in dementia
Sarah Ryan
• 1 Mar 2022
3:36
Understanding tau proteostasis using iPSC
Selina Wray
• 29 Mar 2021
2:02
The role of phosphorylated tau in clinical trials
Elisabeth Thijssen
• 4 Aug 2020
1
2
Next